Company Filing History:
Years Active: 2011-2013
Title: Dawn Ann Bembridge: Innovator in Humanized Antibodies
Introduction
Dawn Ann Bembridge is a notable inventor based in Hertfordshire, GB. She has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of 2 patents, her work has the potential to impact therapeutic approaches for various diseases.
Latest Patents
Dawn's latest patents focus on humanized anti-amyloid beta antibodies. These antibodies are derived from a murine antibody directed to a N-terminal epitope of amyloid beta (Aβ). The humanized antibodies exhibit reduced or no human T cell epitopes while maintaining an affinity for Aβ similar to that of the original murine antibody. This innovation could lead to advancements in treatments for conditions such as Alzheimer's disease.
Career Highlights
Dawn Ann Bembridge is currently associated with Medtronic, Inc., where she continues to push the boundaries of medical technology and innovation. Her expertise in antibody engineering has positioned her as a key player in her field.
Collaborations
Dawn has collaborated with notable colleagues, including Lisa Lynn Shafer and Francis J Carr. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking solutions in biotechnology.
Conclusion
Dawn Ann Bembridge's contributions to the field of humanized antibodies exemplify her dedication to innovation in biotechnology. Her work not only advances scientific understanding but also holds promise for future therapeutic applications.